| abstract |
The present invention relates to enantiomerically pure compounds of formula 1 n n n n n n n n n n wherein the groups m, n, B, X, R 1 , m and Y m− may have the meanings given in the claims and specification, methods for preparing them and their use as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints. |